Table 3.
AS2 for the expression of genes in PseudCap (32) functional classes
Functional category | AS2, % | ||
RPMI | RPMI/serum | LB | |
Adaptation and protection | 75 | 75 | 73 |
Amino acid metabolism and biosynthesis | 84 | 78 | 80 |
Antibiotic resistance and susceptibility | 79 | 79 | 64 |
Biosynthesis of cofactor prosthetic groups and carriers | 86 | 84 | 84 |
Cell division | 94 | 94 | 88 |
Cell wall LPS capsule | 87 | 91 | 89 |
Central intermediary metabolism | 80 | 80 | 76 |
Chaperone and heat shock | 100 | 100 | 94 |
Chemotaxis | 89 | 67 | 78 |
Energy metabolism | 75 | 73 | 72 |
Fatty acid and phospholipid metabolism | 90 | 86 | 86 |
Membrane | 83 | 80 | 73 |
Motility | 90 | 81 | 81 |
Nucleotide biosynthesis and metabolism | 93 | 93 | 75 |
Protein secretion and export | 93 | 100 | 87 |
Putative enzyme | 90 | 88 | 86 |
Secreted factors | 100 | 100 | 67 |
Transcription, RNA processing and degradation | 91 | 91 | 78 |
Transcriptional regulator | 73 | 64 | 59 |
Translation and posttranslational modification | 90 | 88 | 71 |
Transport small molecules | 84 | 81 | 69 |
Two-component regulators | 95 | 89 | 68 |
AS2 for the expression of genes in PseudCap (32) functional classes where transcriptomes from RPMI + 5% MHB (RPMI) and RPMI + 5% MHB + 20% human serum (RPMI/serum) outperformed transcriptomes in LB compared to in vivo transcriptomic data from CF sputum samples and chronic wound. The AS2 represents the percentage of genes within 2 SDs of the mean expression levels in CF sputum and chronic wound samples as determined with z-score calculations using the mean of normalized read counts. Functional categories that performed as well or better than the other in vitro models Mops succinate and SCFM2 are bolded.